Article Details
Retrieved on: 2021-02-01 22:43:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here